Gastrointestinal stromal tumor with KIT mutation in neurofibromatosis type 1

Journal of the Korean Surgical Society

Volumn 81, Issue 4, 2011, Pages 276-280

  Namgung, Hwan ^a  

^a Dankook University   (South Korea)

Author keywords

Gastrointestinal stromal tumors; KIT; Mutation; Neurofibromatosis type 1

Indexed keywords

EID: 81055138942     PISSN: 12260053     EISSN: 20930488     Source Type: Journal    
DOI: 10.4174/jkss.2011.81.4.276     Document Type: Article

References (10)

1. Miettinen M, Fetsch JF, Sobin LH, Lasota J. Gastrointestinal stromal tumors in patients with neurofibromatosis 1: a clinicopathologic and molecular genetic study of 45 cases. Am J Surg Pathol 2006; 30: 90-6. (Pubitemid 43740214)
2. Maertens O, Prenen H, Debiec-Rychter M, Wozniak A, Sciot R, Pauwels P, et al. Molecular pathogenesis of multiple gastrointestinal stromal tumors in NF1 patients. Hum Mol Genet 2006; 15: 1015-23.
3. Takazawa Y, Sakurai S, Sakuma Y, Ikeda T, Yamaguchi J, Hashizume Y, et al. Gastrointestinal stromal tumors of neurofibromatosis type I (von Recklinghausen's disease). Am J Surg Pathol 2005; 29: 755-63. (Pubitemid 40734425)
4. Cheng SP, Huang MJ, Yang TL, Tzen CY, Liu CL, Liu TP, et al. Neurofibromatosis with gastrointestinal stromal tumors: insights into the association. Dig Dis Sci 2004; 49: 1165-9.
5. Yantiss RK, Rosenberg AE, Sarran L, Besmer P, Antonescu CR. Multiple gastrointestinal stromal tumors in type I neurofibromatosis: a pathologic and molecular study. Mod Pathol 2005; 18: 475-84. (Pubitemid 40478110)
6. Mussi C, Schildhaus HU, Gronchi A, Wardelmann E, Hohenberger P. Therapeutic consequences from molecular biology for gastrointestinal stromal tumor patients affected by neurofibromatosis type 1. Clin Cancer Res 2008; 14: 4550-5.
7. Koh JS, Trent J, Chen L, El-Naggar A, Hunt K, Pollock R, et al. Gastrointestinal stromal tumors: overview of pathologic features, molecular biology, and therapy with imatinib mesylate. Histol Histopathol 2004; 19: 565-74. (Pubitemid 38443915)
8. Lasota J, Miettinen M. Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours. Histopathology 2008; 53: 245-66.
9. Yang J, Du X, Lazar AJ, Pollock R, Hunt K, Chen K, et al. Genetic aberrations of gastrointestinal stromal tumors. Cancer 2008; 113: 1532-43.
10. Lee JL, Kim JY, Ryu MH, Kang HJ, Chang HM, Kim TW, et al. Response to imatinib in KIT-and PDGFRA-wild type gastrointestinal stromal associated with neurofibromatosis type 1. Dig Dis Sci 2006; 51: 1043-6. (Pubitemid 44127049)